SCHEMBL6500201

SCHEMBL6500201

O=C(O)c1ccc(C(=O)NCCNc2ccccn2)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
MITF O75030 1/20 0.48
KDM4E B2RXH2 2/20 0.47
HPGD P15428 2/20 0.46
ALDH1A1 P00352 1/20 0.45
POLB P06746 1/20 0.45
PKM P14618 1/20 0.45
FDPS P14324 1/20 0.45
ITGB3 P05106 1/20 0.43
ITGAV P06756 1/20 0.43
MEN1 O00255 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HDAC3 O15379 2/20 0.42
HDAC4 P56524 2/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
CYP1A2 P05177 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6495007 0.89 NPC1 (0.45) KMT2ANPC1RAB9AMITFHPGD
SCHEMBL10401970 0.78 CYP1A2 (0.53) KMT2ANPC1RAB9AHPGDALDH1A1
SCHEMBL30975230 0.77 KMT2A (0.68) KMT2AALDH1A1MEN1HDAC3HDAC4
SCHEMBL10401969 0.75 CYP2C19 (0.56) NPC1RAB9AHPGDALDH1A1PKM
SCHEMBL31483042 0.74 CYP1A2 (0.51) NPC1RAB9AHPGDALDH1A1PKM
SCHEMBL8145501 0.74 CYP1A2 (0.56) NPC1RAB9AALDH1A1PKMFDPS
SCHEMBL3265804 0.72 CYP1A2 (0.70) KMT2ANPC1RAB9AKDM4EHPGD
SCHEMBL5845136 0.72 ITGB3 (0.55) NPC1RAB9APKMITGB3ITGAV
SCHEMBL243759 0.70 ITGB3 (0.63) KMT2ANPC1RAB9AHPGDALDH1A1
SCHEMBL18381352 0.70 ITGB3 (0.62) ALDH1A1ITGB3ITGAVHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6960594-B2 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer SHIRE BIOCHEM INC. (CA) 2005-11-01 US disclosed
US-20020137947-A1 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer BIOCHEM PHARMA INC. 2002-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020137947-A1 Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer ITGB5, ITGB2, ITGA2 KMT2A 2054/4885NPC1 4753/4885RAB9A 1966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.